Novartis collaboration for KAF156 with Medicines for Malaria Venture (MMV)
Posted on16 Jun 2016
Comments0
Novartis AG, a Switzerland-based drug maker, announced that it will further expand its long-standing partnership with Medicines for Malaria Venture (MMV). Under the... Read More